Emcure Pharmaceuticals (NSE:EMCURE) EPS (Basic) : ₹28.44 (TTM As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Emcure Pharmaceuticals EPS (Basic)?

Emcure Pharmaceuticals's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was ₹9.99. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹28.44.

Emcure Pharmaceuticals's EPS (Diluted) for the three months ended in Mar. 2025 was ₹9.99. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹28.44.

Emcure Pharmaceuticals's EPS without NRI for the three months ended in Mar. 2025 was ₹10.41. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 28.86.

During the past 12 months, Emcure Pharmaceuticals's average EPS without NRIGrowth Rate was 37.80% per year. During the past 3 years, the average EPS without NRI Growth Rate was 0.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Emcure Pharmaceuticals's highest 3-Year average EPS without NRI Growth Rate was 0.10% per year. The lowest was -6.20% per year. And the median was -3.05% per year.

Emcure Pharmaceuticals EPS (Basic) Historical Data

The historical data trend for Emcure Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emcure Pharmaceuticals EPS (Basic) Chart

Emcure Pharmaceuticals Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Mar25

EPS (Basic)

21.69

36.63

29.43

26.35

36.43

Emcure Pharmaceuticals Quarterly Data
	Mar21	Mar22	Mar23	Sep23	Dec23	Mar24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial				6.28	6.09	10.33	8.12	9.99

Emcure Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Emcure Pharmaceuticals's Basic EPS for the fiscal year that ended in Mar. 2025 is calculated as

Basic EPS (A: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(6813.32	-	0)	/	187.025
	=	36.43

Emcure Pharmaceuticals's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(1889.57	-	0)	/	189.429
	=	9.98

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹28.44

Emcure Pharmaceuticals (NSE:EMCURE) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Emcure Pharmaceuticals EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Emcure Pharmaceuticals's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Emcure Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emcure Pharmaceuticals Ltd (NSE:EMCURE) » Definitions » EPS (Basic)

Traded in Other Exchanges

544210:India

Address

Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Hinjawadi, MH, IND, 411057

Website

https://www.emcure.com

Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics.

Emcure Pharmaceuticals Headlines

No Headlines